Patient advocates have become critical stakeholders and collaborators in the biotech field, shaping research priorities and clinical trial design as well as informing strategies to get innovative treatments to patients. This panel discussion will feature influential voices in patient advocacy, including empowered patients, care partners and advocate groups, and biotech industry leaders. Together, we’ll explore new approaches to partnering with patient advocates to drive better outcomes for patients, with an emphasis on the need to develop a deeper level of understanding of the patient’s experience.